This article provides a comprehensive overview of contemporary strategies to enhance the accuracy of target prediction for natural products (NPs), a critical bottleneck in modern drug discovery.
Missing data is a pervasive and non-trivial challenge in multi-omics studies, frequently arising from technical limitations, cost constraints, or biological factors, and can severely compromise integrated analyses if mishandled [citation:3].
This article provides a comprehensive guide for researchers and drug development professionals on optimizing molecular docking workflows specifically for structurally related natural compounds and their analogs.
This article provides a comprehensive exploration of cutting-edge feature enhancement techniques in network pharmacology, a paradigm-shifting approach in drug discovery.
This article provides a comprehensive roadmap for implementing robust data standardization to unlock the full potential of Artificial Intelligence (AI) in natural product research.
As artificial intelligence reshapes drug discovery and development, the 'black box' nature of complex models has emerged as a critical bottleneck for regulatory approval, clinical translation, and scientific trust.
This article provides a comprehensive analysis of the 'black box' problem in AI for drug discovery, addressing the critical need for transparency among researchers and development professionals.
This article provides a comprehensive analysis for researchers and drug development professionals on overcoming the critical data limitations hindering AI pharmacology models.
This article explores the transformative role of artificial intelligence (AI) in the de novo design of natural product-derived molecules for drug discovery.
This article provides a comprehensive overview for researchers, scientists, and drug development professionals on the transformative role of Natural Language Processing (NLP) in mining pharmacological data.